ClinicalTrials.Veeva

Menu

RESponders and QUadripolar LV Lead in CRT (ResQ CRT)

O

Ospedale Santa Croce-Carle Cuneo

Status

Unknown

Conditions

Heart Failure

Treatments

Device: CRTD

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to observe the evolution of the CRTD system with left quadripolar lead, in terms of electrical parameters in all pacing configurations and to evaluate the impact on the clinical outcome.

Full description

Cardiac resynchronization therapy (CRT) is limited by a high proportion of non-responders.

Pacing activation from proximal area with a left quadripolar lead might improve the depolarization pattern.

To explore the effect of CRT pacing on cardiac activity, the investigators will enroll approximately 180 patients who already underwent CRT-D implantation with a quadripolar LV lead.

After implant, as clinical practice, the device will be programmed with distal LV pacing configuration, after 6 months in patient non-responders to CRT therapy the pacing configuration will be changed (proximal configuration).

After 12 months in patients non-responders will be changed the pacing configuration again, choosing, if it is possible, a multi point pacing (pacing activation from multiple separated left ventricular (LV) sites).

Enrollment

180 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Be in NYHA II, III or IV functional class with approved standard indication by ESC/EHRA Guidelines
  • Successful quadripolar LV lead implant

Exclusion criteria

  • Less than 18 years of age
  • Epicardial Lead
  • Life expectancy < 12 months
  • Pregnant or are planning to become pregnant during the duration of the investigation

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems